Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction

Urology

Volumn 56, Issue 2, 2000, Pages 346-351

  Jones, Eric A ^a,b   Shahed, Asha ^a,b   Shoskes, Daniel A ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b DEPARTMENT OF COLORECTAL SURGERY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BIOFLAVONOID; CHEMOKINE; CURCUMIN; DIMETHYL SULFOXIDE; ENALAPRIL; FAS ANTIGEN; FAS LIGAND; LOSARTAN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; KIDNEY INJURY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; URETER OBSTRUCTION;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CHEMOKINES; CURCUMIN; DISEASE MODELS, ANIMAL; FLAVONOIDS; GENE EXPRESSION; KIDNEY DISEASES; MALE; NEPHRITIS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; URETERAL OBSTRUCTION;

EID: 0033941059     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00608-7     Document Type: Article

References (30)

1. Klahr S., Buekert J., Purkerson M.L. The kidney in obstructive uropathy. Contrib Nephrol. 7:1977;220-225.
2. Diamond J.R., Kees-Folts D., Ding G., et al. Macrophages, monocyte chemoattractant peptide-1 and TGF-β1 in experimental hydronephrosis. Am J Phys. 266:(6 Pt 2):1994;F926-F933.
3. Ishidoya S., Morrissey J.J., McCracken R., et al. Angiotensin II receptor antagonist ameliorates tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int. 47:1995;1285-1294.
4. Shoskes D.A. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury. Transplantation. 66:1998;147-152.
5. Chomczynzki P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
6. Nadeau K.C., Azuma H., Tilney N.L. Sequential cytokine dynamics in chronic rejection of rat renal allografts roles for cytokines RANTES and MCP-1 . Proc Natl Acad Sci USA. 92:1995;8729-8733.
7. Goodman A.I., Choudhury M., da Silva J.L., et al. Overexpression of the heme oxygenase gene in renal cell carcinoma. J Exp Biol Med. 214:1997;54-61.
8. Truong L.D., Sheikh-Hamad D., Chakraborty S., et al. Cell apoptosis and proliferation in obstructive nephropathy. Semin Nephrol. 18:1998;641-651.
9. Hinman F. Hydronephrosis. I, the structural change. II, the functional change. III, hydronephrosis and hypertension. Surgery. 17:1945;816-849.
10. Schreiner G.F., Harris K.P., Purkerson M.L., et al. Immunological aspects of acute ureteral obstruction Immune cell infiltrate in the kidney . Kidney Int. 34:1988;487-493.
11. Morrissey J.J., Klahr S. Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol. 274:(3 Pt 2):1998;F580-F586.
12. Singh S., Aggarwal B.B. Activation of transcription factor nuclear factor kB is suppressed by curcumin (diferoloylmethane). J Biol Chem. 270:1995;24995-25000.
13. Commandeur J., Vermeulen N. Cytotoxicity and cytoprotective activities of natural compounds the case of curcumin . Xenobiotica. 26:1996;667-680.
14. Jones E.A., Shoskes D.A. The effect of polyphenolic compounds on renal injury and repair. J Urol. 163:2000;999-1004.
15. Morrissey J.J., Klahr S. Enalapril decreases nuclear factor kB activation in the kidney with ureteral obstruction. Kidney Int. 52:1997;926-933.
16. Peter M., Heufelder A.E., Hengartner M.O. Advances in apoptosis research. Proc Natl Acad Sci USA. 94:1997;12736-12737.
17. Tsutsui H., Nakanishi K., Matsui K., et al. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol. 157:1996;3967-3973.
18. Takemura T., Murakami K., Miyazato H., et al. Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int. 48:1995;1886-1892.
19. Ortiz-Arduan A., Danoff T.M., Kalluri R., et al. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol. 271:1996;F1193-F1201.
20. Hughes J., Johnson R.J. Role of Fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction. Am J Physiol. 277:1999;F26-F32.
21. Sreejayan, Rao M.N. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol. 46:1994;1013-1016.
22. Hanasaki Y., Ogawa S., Fukui S. The correlation between active oxygen scavenging and antioxidative effects of flavonoids. Free Radic Biol Med. 16:1994;845-850.
23. Singhal R.L., Yeh Y.A., Praja N. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun. 208:1995;425-431.
24. Maines M.D. The heme oxygenase system a regulator of second messenger gases . Annu Rev Pharmacol Toxicol. 37:1997;517-554.
25. Sagara Y., Dargusch R., Chambers D., et al. Cellular mechanisms of resistance to chronic oxidative stress. Free Radic Biol Med. 24:1998;1375-1389.
26. Stocker R. Induction of haeme oxygenase as a defense against oxidative stress. Free Radic Biol Med. 9:1990;101-112.
27. Choi A.M., Alam J. Heme oxygenase-1 function, regulation and implication of a novel stress inducible protein in oxidant induced lung injury . Am J Respir Cell Mol Biol. 15:1996;9-19.
28. Panahian N., Yoshiura M., Maines M.M. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem. 72:1999;1187-1203.
29. Kawada N., Moriyama T., Ando A., et al. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 56:1999;1004-1013.
30. Shoskes D.A., Zeitlin S.I., Shahed A., et al. Quercetin in men with category III chronic prostatitis a preliminary prospective, double blind, placebo-controlled trial . Urology. 54:1999;960-963.